Edited by Phillip Smith, Drug Reporter provides coverage of drug policy in its many manifestations: marijuana policy and medical marijuana; the opioid crisis; new psychoactive substances and psychedelics; stimulants; sentencing policy and corrections; drug testing of students, workers, and benefits-seekers; and the intersection of drug policy with reproductive rights—as well as drug culture (mainly marijuana; psychedelics and stimulants to a lesser degree) and health issues that relate to drug policy, such as addiction and addiction treatment, and health benefits/negatives of various substances.

Project News


There are no Fellows in this Project.

Drug Reporter Newsletter Signup

Change the way you think about the world. Keep up with Drug Reporter:


    Netflix is raising their prices—again.

    It pays for glitzy TV, not quality news.

    Please support the talented journalists at IMI!

    Join Us

    Sign up to get news from Drug Reporter and IMI delivered straight to your inbox: